SCHEMBL1170660

SCHEMBL1170660

c1ccc(CNc2nc3ccccc3n2Cc2ccccc2)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.86
MAPT P10636 1/20 0.86
TRPC4 Q9UBN4 1/20 0.73
TRPC5 Q9UL62 1/20 0.73
CYP1A2 P05177 3/20 0.70
CYP2C19 P33261 3/20 0.70
SMN1; SMN2 Q16637 3/20 0.70
CYP3A4 P08684 2/20 0.70
CYP2D6 P10635 2/20 0.70
CYP2C9 P11712 2/20 0.70
HKDC1 Q2TB90 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
LMNA P02545 3/20 0.60
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
ALPL P05186 1/20 0.60
PKM P14618 1/20 0.60
HTT P42858 1/20 0.60
DRD2 P14416 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1170123 0.89 SMN1; SMN2 (0.74) ALDH1A1MAPTTRPC4TRPC5CYP1A2
SCHEMBL1169982 0.88 ALDH1A1 (0.69) ALDH1A1MAPTTRPC4TRPC5CYP1A2
SCHEMBL22619593 0.85 TRPC5 (1.00) ALDH1A1MAPTTRPC4TRPC5SMN1; SMN2
SCHEMBL29646286 0.85 TRPC5 (1.00) ALDH1A1MAPTTRPC4TRPC5SMN1; SMN2
SCHEMBL1170118 0.83 KMT2A (0.64) ALDH1A1MAPTTRPC4TRPC5CYP1A2
SCHEMBL28805359 0.83 MAPT (0.62) ALDH1A1MAPTTRPC4TRPC5CYP1A2
Hydrochloric Acid SCHEMBL28745357 0.83 CYP1A2 (0.66) ALDH1A1MAPTTRPC4TRPC5CYP1A2
SCHEMBL30218922 0.82 SMN1; SMN2 (0.64) ALDH1A1MAPTTRPC4TRPC5CYP1A2
SCHEMBL28972173 0.82 SMN1; SMN2 (0.64) ALDH1A1MAPTTRPC4TRPC5CYP1A2
SCHEMBL19713871 0.82 CYP1A2 (0.63) ALDH1A1MAPTTRPC4TRPC5CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103044337-A Synthetic method of 2-(N-alkyl)aminooimidazole derivatives UNIV NANJING SCIENCE & TECH 2013-04-17 CN disclosed
EP-2319512-A1 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels. NeuroSearch AS (DK) 2011-05-11 EP disclosed
US-20110034527-A1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS SOERENSEN ULRIK SVANE 2011-02-10 US disclosed
US-7842817-B2 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels NEUROSEARCH A/S (DK) 2010-11-30 US disclosed
EP-1838306-B1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS NEUROSEARCH AS (DK) 2010-11-17 EP disclosed
US-20100280087-A1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS SOERENSEN ULRIK SVANE 2010-11-04 US disclosed
US-20080200529-A1 Novel 2-Amino Benzimidazole Derivatives and Their Use As Modulators Of Small-Conductance Calcium-Activated Potassium Channels NEURO SEARCH A/S (DK) 2008-08-21 US disclosed
EP-1838306-A1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS NEUROSEARCH A/S (DK) 2007-10-03 EP disclosed
WO-2006074991-A1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS NEUROSEARCH A/S (DK) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110034527-A1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS KCNN2, KCNN1, KCNN3 ALDH1A1 3979/4885MAPT 1733/4885TRPC4 77/4885
US-20080200529-A1 Novel 2-Amino Benzimidazole Derivatives and Their Use As Modulators Of Small-Conductance Calcium-Activated Potassium Channels KCNN2, KCNN1, KCNN3 ALDH1A1 3979/4885MAPT 1733/4885TRPC4 77/4885
US-20100280087-A1 NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS KCNN2, KCNN1, KCNN3 ALDH1A1 3979/4885MAPT 1733/4885TRPC4 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.